Abstract
This Frost & Sullivan research service entitled The U.S. Anticoagulant Market
provides an analysis of the following areas: warfarin, heparins, direct
thrombin inhibitors, synthetic pentasaccharides, and emerging new mechanism
anticoagulants. Major trends and technologies are discussed as well as revenue
forecasts, market shares and product pipeline overviews. The study also
highlights key industry challenges, and market drivers and restraints that are
expected to impact the market.
View Cart
